Primary human papillomavirus DNA screening with cytology triage in a routine organized screening program detects more cervical intraepithelial neoplasia III+ lesions in all age groups than conventional cytology, according to new study findings.
Primary human papillomavirus (HPV) DNA screening with cytology triage in a routine organized screening program detects more cervical intraepithelial neoplasia (CIN) III+ lesions in all age groups than conventional cytology, according to the findings of a recent randomized, population-based, longitudinal study from Finland.
In the study, which included data on more than 58,000 women, the relative rate of CIN III+ lesions in the HPV group versus the conventional group was 1.44 (95% CI, 1.01-2.05) among all women invited to participate and 1.77 (95% CI, 1.16-2.74) among those who were actually screened. The rate of cervical cancer between arms was 0.75 (95% CI, 0.25-2.16) among invitees and 1.98 (95% CI, 0.52-9.38) among attendees.
Among women with a normal or negative test result, the relative rate between groups of subsequent CIN III+ was 0.28 (95% CI, 0.04-1.17), suggesting a lower rate of CIN III+ for HPV screening than for conventional cytology.
Anttila A, Kotaniemi-Talonen L, Leionen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organized screening programme. BMJ. 2010;340:c1804.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More